Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02847494 · ClinicalTrials.gov registry record · Phase 4
Corticosteroids for Acute Migraine in the Emergency Department
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
NCT02847494 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 220 participants.
The verdict
NCT02847494, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
Study Summary
This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.
Interventions
- DRUG Dexamethasone
- DRUG metoclopramide
- DRUG methylprednisolone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02847494
The ClinicalTrials.gov registry entry for NCT02847494 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexamethasone is the first listed.
NCT02847494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02847494 about?
NCT02847494 is a clinical study titled "Corticosteroids for Acute Migraine in the Emergency Department". This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.
What is the current status of trial NCT02847494?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2016-09-01. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT02847494?
The interventions under investigation include: Dexamethasone (DRUG), metoclopramide (DRUG), methylprednisolone acetate (DRUG).
Who is sponsoring clinical trial NCT02847494?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.